{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T03:02:35Z","timestamp":1783393355077,"version":"3.54.6"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T00:00:00Z","timestamp":1622160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Venous thromboembolic events (VTE) are commonly encountered in patients with lymphoma. Several risk assessments models (RAM) had attempted to identify higher risk patients with varying success. The International Prognostic Index (IPI) is a clinicopathological tool developed to help predict both response to treatment and prognosis of patients with diffuse large B-cell lymphoma (DLBCL).<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>In this study, we utilize the IPI index to identify group of patients with DLBCL at higher risk for VTE.<\/jats:p><\/jats:sec><jats:sec><jats:title>Patients\/Methods<\/jats:title><jats:p>Patients with pathologically-confirmed diagnosis of DLBCL and with image-confirmed VTE, treated and followed at our institution were included. Rates of VTE was calculated for each risk category.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 373 patients, median age 49 (range: 18-90) years were included. VTE were reported in 56 (15.0%) patients; 51 (91.1%) had active disease while 29 (51.8%) were ambulatory at time of VTE diagnosis. VTE rates were particularly high among patients with poor performance status (26.2%, P=0.028) and high LDH (19.0%, P=0.023). Applying the age-adjusted IPI separated patients into two risk categories; VTE were diagnosed in 9.7% in patients with \u201clow and low-intermediate\u201d scores compared to 19.8% in patients with \u201chigh and high-intermediate\u201d scores, P=0.020.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The original IPI and its modified versions, routinely used at diagnosis as a prognostic and predictive tool for patients with DLBCL, can also be utilized to define high risk patients for VTE; the risk of whom might be high enough to recommend thromboprophylaxis even in the ambulatory settings. More work is needed to refine and improve currently available RAMs.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2021.677776","type":"journal-article","created":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T08:23:09Z","timestamp":1622190189000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["The Application of the Lymphoma International Prognostic Index to Predict Venous Thromboembolic Events in Diffuse Large B-Cell Lymphoma Patients"],"prefix":"10.3389","volume":"11","author":[{"given":"Hikmat","family":"Abdel-Razeq","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Ma\u2019koseh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashid","family":"Abdel-Razeq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rula","family":"Amarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa","family":"Abufara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razan","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Manasrah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Al-Rwashdeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rayan","family":"Bater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,5,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-04-460121","article-title":"Epidemiology of Cancer-Associated Venous Thrombosis","volume":"122","author":"Timp","year":"2013","journal-title":"Blood"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1097\/CCO.0b013e3283592331","article-title":"Venous Thromboembolism in the Hematologic Malignancies","volume":"24","author":"Falanga","year":"2012","journal-title":"Curr Opin Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-01-258624","article-title":"Thrombotic Complications in Adult Patients With Lymphoma: A Meta-Analysis of 29 Independent Cohorts Including 18 018 Patients and 1149 Events","volume":"115","author":"Caruso","year":"2010","journal-title":"Blood"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2007.02374.x","article-title":"Thromboembolism is a Leading Cause of Death in Cancer Patients Receiving Outpatient Chemotherapy","volume":"5","author":"Khorana","year":"2007","journal-title":"J Thromb Haemost"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.2174\/157488707780599348","article-title":"New Treatment Concepts in Diffuse Large B-cell Lymphomas (DLBL): Chemothe-Rapy and Biological Therapy","volume":"2","author":"Rodriguez","year":"2007","journal-title":"Rev Recent Clin Trials"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 Revision of the World Health Organization Classification of Lymphoid Neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25765","article-title":"Racial Differences in the Presentation and Outcomes of Diffuse Large B-Cell Lymphoma in the United States","volume":"117","author":"Shenoy","year":"2011","journal-title":"Cancer"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-010-0509-x","article-title":"Venous Thromboembolism (VTE) in Hospitalized Cancer Patients: Prophylaxis Failure or Failure to Prophylax","volume":"31","author":"Abdel-Razeq","year":"2011","journal-title":"J Thromb Thrombolysis"},{"key":"B9","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s11239-017-1542-9","article-title":"Venous Thromboembolism Prophylaxis for Ambulatory Cancer Patients, Can We do Better","volume":"44","author":"Abdel-Razeq","year":"2017","journal-title":"J Thromb Thrombolysis"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-10-116327","article-title":"Development and Validation of a Predictive Model for Chemotherapy-Associated Thrombosis","volume":"111","author":"Khorana","year":"2008","journal-title":"Blood"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-02-270116","article-title":"Prediction of Venous Thromboembolism in Cancer Patients","volume":"116","author":"Ay","year":"2010","journal-title":"Blood"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2016-0414","article-title":"A Predictive Score for Thrombosis Associated With Breast, Colorectal, Lung, or Ovarian Cancer: The Prospective COMPASS-Cancer-Associated Thrombosis Study","volume":"22","author":"Gerotziafas","year":"2017","journal-title":"Oncologist"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2015-0361","article-title":"A Validated Risk Score for Venous Thromboembolism Is Predictive of Cancer Progression and Mortality","volume":"21","author":"Kuderer","year":"2016","journal-title":"Oncologist"},{"key":"B14","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1016\/S0169-5002(16)30132-5","article-title":"115 Predictors of Active Cancer Thromboembolic Outcomes: Validation of the Khorana Score Among Patients With Lung Cancer","volume":"91","author":"Mansfield","year":"2016","journal-title":"Lung Cancer"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2016.12.013","article-title":"The Khorana Score for the Prediction of Venous Thromboembolism in Patients With Pancreatic Cancer","volume":"150","author":"van Es","year":"2017","journal-title":"Thromb Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1177\/1076029617699088","article-title":"Performance of Khorana Risk Score for Prediction of Venous Thromboembolism in Patients With Hepatocellular Carcinoma","volume":"24","author":"Wang","year":"2018","journal-title":"Clin Appl Thromb Hemost"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1177\/1076029617692880","article-title":"The Application of Current Proposed Venous Thromboembolism Risk Assessment Model for Ambulatory Patients With Cancer","volume":"24","author":"Abdel-Razeq","year":"2018","journal-title":"Clin Appl Thromb Hemost"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24466","article-title":"Development and Validation of Multivariable Predictive Model for Thromboembolic Events in Lymphoma Patients: Multivariable Predictive Model","volume":"91","author":"Antic","year":"2016","journal-title":"Am J Hematol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2017.10.002","article-title":"Venous Thromboembolic Events in Lymphoma Patients: Actual Relationships Between Epidemiology, Mechanisms, Clinical Profile and Treatment","volume":"32","author":"Antic","year":"2018","journal-title":"Blood Rev"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.1271","article-title":"Simplicity At the Cost of Predictive Accuracy in Diffuse Large B-Cell Lymphoma: A Critical Assessment of the R-IPI, IPI, and NCCN-IPI","volume":"7","author":"Biccler","year":"2018","journal-title":"Cancer Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019002729","article-title":"International Prognostic Indices in Diffuse Large B-Cell Lymphoma: A Comparison of IPI, R-IPI, and NCCN-IPI","volume":"135","author":"Ruppert","year":"2020","journal-title":"Blood"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-02-142422","article-title":"High Plasma Levels of Soluble P-selectin are Predictive of Venous Thromboembolism in Cancer Patients: Results From the Vienna Cancer and Thrombosis Study (Cats)","volume":"112","author":"Ay","year":"2008","journal-title":"Blood"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.1540","article-title":"Evaluation of the ThroLy Score for the Prediction of Venous Thromboembolism in Newly Diagnosed Patients Treated for Lymphoid Malignancies in Clinical Practice","volume":"7","author":"Rupa-Matysek","year":"2018","journal-title":"Cancer Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjms.2017.02.002","article-title":"The Enhanced International Prognostic Index for Diffuse Large B-Cell Lymphoma","volume":"353","author":"Yang","year":"2017","journal-title":"Am J Med Sci"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25460","article-title":"Diffuse Large B-Cell Lymphoma: 2019 Update on Diagnosis, Risk Stratification, and Treatment","volume":"94","author":"Liu","year":"2019","journal-title":"Am J Hematol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.677776\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T08:23:10Z","timestamp":1622190190000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.677776\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,28]]},"references-count":25,"alternative-id":["10.3389\/fonc.2021.677776"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2021.677776","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,28]]},"article-number":"677776"}}